Market Research Report

Cyberonics, Inc. Market Share Analysis
cover Published by GlobalData
Published Product code 244221
Content info Pages: 88
Price

Introduction

Abstract

Cyberonics, Inc. Market Share Analysis

Summary

GlobalData's new report, "Cyberonics, Inc. Market Share Analysis" provides in-depth information on Cyberonics, Inc.'s market position in the different medical equipment markets it operates in. The report provides Cyberonics, Inc. market share information in one key market category - Neurostimulation Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Global company shares (in Revenues) information for the key markets Cyberonics, Inc. operates in - Neurology Devices.
  • Cyberonics, Inc.'s company shares (in Revenues) information for all the key countries the company has presence in - India, Japan, Australia, China, United Kingdom, France, Germany, Italy, Spain, Canada, United States and Brazil.
  • Cyberonics, Inc.'s company shares (in Revenues) information for all the key market category the company has presence in - Neurostimulation Devices.
  • All the key data-points are for 2011 and cover all the key regions - North America, Europe, Asia-Pacific, South and Central America and Middle East and Africa.
  • Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries.
  • Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

  • Develop sales and marketing strategies by identifying who-stands-where in the markets, Cyberonics, Inc. operates in.
  • Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.
  • Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
  • Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
  • Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Cyberonics, Inc.'s market positions.

Table of Contents

TOC

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 7
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 What Is This Report About? 8

3 Definitions of Markets/Categories Covered 9

  • 3.1 Neurology Devices 9
    • 3.1.1 Neurostimulation Devices 9

4 Company Snapshot 10

  • 4.1 Key Facts 10
  • 4.2 Company Overview 10
  • 4.3 Financial Performance 10
  • 4.4 Business Overview 11

4.5 Major Products and Services 12

    • 4.5.1 Overview 12

5 History 13

6 Competitors 15

7 Competitive Landscape 16

  • 7.1 Neurology Devices (Neurostimulation Devices), Global, Market Share (%), 2011 16
  • 7.2 Cyberonics, Inc., Neurology Devices(Neurostimulation Devices), by Region, Market Share (2011) 17
  • 7.3 Cyberonics, Inc., Neurology Devices(Neurostimulation Devices), by Country, Market Share (2011) 18

8 Key Employees 20

9 Key Employee Biographies 21

10 Company Statement 22

11 Locations And Subsidiaries 24

  • 11.1 Head Office 24
  • 11.2 Other Locations & Subsidiaries 24

12 Financial Deals Landscape 25

  • 12.1 Cyberonics, Inc., Deals Volume Summary, 2006 to YTD 2012 25

13 Cyberonics, Inc. Detailed Deal Summary 27

  • 13.1 Venture Financing 27
    • 13.1.1 IMTHERA MEDICAL Secures $4 Million In Series C Venture Financing 27
  • 13.2 Partnerships 28
    • 13.2.1 Cyberonics Enters Into Licensing Agreement With NeuroVista 28
    • 13.2.2 Cyberonics Enters Into Licensing Agreement With Massachusetts Institute of Technology 29
    • 13.2.3 Cyberonics Enters Into Licensing Agreement With Southern Illinois University 30
    • 13.2.4 Cyberonics Enters Into Licensing Agreement With Ethicon Endo-Surgery 31
    • 13.2.5 Cyberonics Signs An Agreement With Nihon Kohden 32
    • 13.2.6 NeuroVista Secures $5 Million In Debt From Cyberonics 33
  • 13.3 Acquisition 34
    • 13.3.1 Boston Scientific Sells Its Stake In Cyberonics 34

14 Recent Developments 35

  • 14.1 Strategy And Business Planning 35
    • 14.1.1 Aug 24, 2010: Cyberonics Signs Epilepsy Technology Agreements With NeuroVista In Field Of EEG-based Seizure Detection 35
  • 14.2 Financial Announcements 35
    • 14.2.1 Feb 24, 2012: Cyberonics Reports Revenue Of $54.5m In Q3 Fiscal 2012 35
    • 14.2.2 Nov 18, 2011: Cyberonics Reports Revenues Of $53.7m In Q2 Fiscal 2012 38
    • 14.2.3 Aug 25, 2011: Cyberonics Reports Net Sales Of $52.7m In Q1 Fiscal 2012 38
    • 14.2.4 Jun 02, 2011: Cyberonics Reports Net Sales Of $190.5m In Fiscal Year Ended 2011 39
    • 14.2.5 Mar 02, 2011: Cyberonics Reports Net Income Of $7.2m In Q3 Fiscal Year Ended 2011 40
    • 14.2.6 Nov 22, 2010: Cyberonics Reports Net Income Of $24.9 Million For Q2 Fiscal 2011 42
    • 14.2.7 Aug 25, 2010: Cyberonics Reports Net Income Of $7.16 Million In Q1 Fiscal 2011 43
    • 14.2.8 Jun 02, 2010: Cyberonics Reports Net Sales Of $167.8 Million In Fiscal 2010 45
    • 14.2.9 Feb 17, 2010: Cyberonics Reports Net Sales Of $40.8m In Q3 Fiscal Year Ended 2010 46
    • 14.2.10 Nov 18, 2009: Cyberonics Reports Net Income Of $50.1 Million In Q2 Fiscal 2010 48
    • 14.2.11 Aug 19, 2009: Cyberonics Posts Net Income Of $7.9 Million In Q1 Fiscal 2010 50
    • 14.2.12 Jun 03, 2009: Cyberonics Posts Net Income Of $26.7 Million In Fiscal 2009 51
    • 14.2.13 Feb 18, 2009: Cyberonics Reports Q3 Fiscal 2009 Results 53
    • 14.2.14 Nov 19, 2008: Cyberonics Reports 2Q Fiscal 2009 Results 55
    • 14.2.15 Aug 21, 2008: Cyberonics Reports 1Q Fiscal 2009 Results 57
    • 14.2.16 Jun 11, 2008: Cyberonics Reports Q4 Fiscal 2008 Results 59
    • 14.2.17 Feb 20, 2008: Cyberonics Declares Q3 Fiscal 2008 Results 61
    • 14.2.18 Nov 19, 2007: Cyberonics Declares Q2 Fiscal 2008 Results 64
    • 14.2.19 Aug 29, 2007: Cyberonics Reports Q1 Fiscal 2008 Results 65
    • 14.2.20 Jun 11, 2007: Cyberonics Reports Fiscal Year 2007 Results 65
    • 14.2.21 Feb 23, 2007: Cyberonics Reports Q3 Fiscal 2007 Results 66
  • 14.3 Corporate Communications 67
    • 14.3.1 Oct 10, 2011: Cyberonics Announces Resignation Of James A Reinstein As Senior Vice President And Chief Commercial Officer 67
    • 14.3.2 Aug 09, 2010: Cyberonics Nominates Jon T. Tremmel To Stand As Director To Board 67
    • 14.3.3 May 18, 2009: Cyberonics Appoints Bryan Olin As Vice President, Quality 68
    • 14.3.4 Jan 12, 2009: Cyberonics Appoints Vice President, Research And Development 68
    • 14.3.5 Nov 21, 2008: Cyberonics To Present At Piper Jaffray Conference 69
    • 14.3.6 Sep 11, 2008: Cyberonics's CEO To Present At UBS Conference 69
    • 14.3.7 Aug 26, 2008: Cyberonics To Present At Thomas Weisel Partners Healthcare Conference 69
    • 14.3.8 Aug 07, 2008: Cyberonics Nominates New Board Member 69
    • 14.3.9 Jul 09, 2007: Cyberonics Appoints New CFO 70
    • 14.3.10 May 01, 2007: Cyberonics Appoints New CEO 70
    • 14.3.11 Jan 29, 2007: Cyberonics Announces Board Changes 71
  • 14.4 Legal and Regulatory 71
    • 14.4.1 Apr 21, 2008: Cyberonics Announces Settlement Of Convertible Note Litigation 71
  • 14.5 Product News 72
    • 14.5.1 Jan 03, 2012: Cyberonics Announces FDA Approval Of Re-Designed AspireHC Generator For VNS Therapy 72
    • 14.5.2 Oct 31, 2011: Cyberonics Receives FDA Approval For Expansion Of MRI Use With VNS Therapy Systems 72
    • 14.5.3 Oct 31, 2011: Cyberonics Receives FDA Approval For Expansion Of MRI Use With VNS Therapy Systems 72
    • 14.5.4 Oct 24, 2011: Cyberonics Announces Submission Of AspireHC Generator For Regulatory Approvals 73
    • 14.5.5 May 02, 2011: Cyberonics Announces First Implant Of AspireSR Seizure Response Product In European Trial 73
    • 14.5.6 Feb 01, 2011: Cyberonics Announces FDA Approval Of Aspire High Capacity Generator For VNS Therapy 74
    • 14.5.7 Dec 21, 2010: Emory University School Of Medicine Presents Study Results Of Cyberonics's VNS Therapy System 74
    • 14.5.8 Nov 05, 2010: Cyberonics Confirms Safety And Efficacy Of VNS Therapy 75
    • 14.5.9 Dec 04, 2009: Cyberonics' Vagus Nerve Stimulation (VNS) Therapy System To Be Featured At The AES Meeting 76
    • 14.5.10 Jul 24, 2009: FDA Approves Cyberonics' Proposal To Amend The Protocol Of Its D-21 Post-Approval Dosing Study 77
    • 14.5.11 Jan 07, 2009: Cyberonics Presents Business Updates On Depression Clinical Trial 77
    • 14.5.12 Oct 01, 2008: Cyberonics Provides Update On Depression Indication 77
  • 14.6 Product Approvals 78
    • 14.6.1 Jan 03, 2012: Cyberonics Announces FDA Approval Of Re-Designed AspireHC Generator For VNS Therapy 78
    • 14.6.2 Oct 31, 2011: Cyberonics Receives FDA Approval For Expansion Of MRI Use With VNS Therapy Systems 78
    • 14.6.3 Oct 31, 2011: Cyberonics Receives FDA Approval For Expansion Of MRI Use With VNS Therapy Systems 78
  • 14.7 Clinical Trials 79
    • 14.7.1 May 02, 2011: Cyberonics Announces First Implant Of AspireSR Seizure Response Product In European Trial 79
    • 14.7.2 Dec 21, 2010: Emory University School Of Medicine Presents Study Results Of Cyberonics's VNS Therapy System 79
  • 14.8 Other Significant Developments 81
    • 14.8.1 Aug 15, 2011: Cyberonics Announces Hold On Shipment And Retrieval Of Inventory Of AspireHC and AspireSR Generators 81
    • 14.8.2 Nov 21, 2008: Cyberonics To Present At Piper Jaffray Conference 81
    • 14.8.3 Sep 15, 2008: Cyberonics Provides Operations Updates Following Hurricane Ike 81
    • 14.8.4 Sep 11, 2008: Cyberonics's CEO To Present At UBS Conference 81
    • 14.8.5 Aug 26, 2008: Cyberonics To Present At Thomas Weisel Partners Healthcare Conference 82
    • 14.8.6 Dec 18, 2007: Cyberonics Signs Agreement With Ethicon To License Its Patents Of Obesity Treatment 82

15 Appendix 83

  • 15.1 Research Methodology 84
  • 15.2 Secondary Research 84
  • 15.3 Primary Research 85
  • 15.4 Models 85
  • 15.5 Forecasts 85
  • 15.6 Expert Panels 86
  • 15.7 GlobalData Consulting 86
  • 15.8 Currency Conversion 87
  • 15.9 Contact Us 88
  • 15.10 Disclaimer 88

List of Tables

1.1 List of Tables

  • Table 1: Cyberonics, Inc., Key Facts, 2011 10
  • Table 2: Neurology Devices (Neurostimulation Devices), Global, Company Share by Revenue ($m), 2011 16
  • Table 3: Cyberonics, Inc., Neurology Devices (Neurostimulation Devices), by Region, Revenue ($m) and Market Share (%), 2011 17
  • Table 4: Cyberonics, Inc., Neurology Devices (Neurostimulation Devices), by Country, Revenue ($m) and Market Share (%), 2011 19

Table 5: Cyberonics, Inc., Key Employees 20

  • Table 6: Cyberonics, Inc., Other Locations 24
  • Table 7: Cyberonics, Inc., Subsidiaries 24
  • Table 8: Cyberonics, Inc., Deals Volume Summary, 2006 to YTD 2012 25
  • Table 9: Cyberonics, Inc., Deals Summary, 2006 to YTD 2012 26
  • Table 10: IMTHERA MEDICAL Secures $4 Million In Series C Venture Financing 27
  • Table 11: Cyberonics Enters Into Licensing Agreement With NeuroVista 28
  • Table 12: Cyberonics Enters Into Licensing Agreement With Massachusetts Institute of Technology 29
  • Table 13: Cyberonics Enters Into Licensing Agreement With Southern Illinois University 30
  • Table 14: Cyberonics Enters Into Licensing Agreement With Ethicon Endo-Surgery 31
  • Table 15: Cyberonics Signs An Agreement With Nihon Kohden 32
  • Table 16: NeuroVista Secures $5 Million In Debt From Cyberonics 33
  • Table 17: Boston Scientific Sells Its Stake In Cyberonics 34
  • Table 18: USD to Local Currency, Average Exchange Rate, 2011 87

List of Figures

1.2 List of Figures

  • Figure 1: Neurology Devices (Neurostimulation Devices), Global, Market Share (%), 2011 16
  • Figure 2: Cyberonics, Inc., Neurology Devices (Neurostimulation Devices), by Region, Market Share (%), 2011 17
  • Figure 3: Cyberonics, Inc., Neurology Devices (Neurostimulation Devices), by Country, Market Share (%), 2011 18
  • Figure 4: Cyberonics, Inc., Deals Volume Summary, 2006 to YTD 2012 25

Cyberonics, Inc. Market Share Analysis published by GlobalData in May 31, 2012. This report consists of Pages: 88 and the price starts from US $ 1000.

The contents of this page may be different from the latest version. Please contact us for details.
Back to Top